These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 16626703)

  • 1. Focus on molecules: cystatin C.
    Paraoan L; Grierson I
    Exp Eye Res; 2007 Jun; 84(6):1019-20. PubMed ID: 16626703
    [No Abstract]   [Full Text] [Related]  

  • 2. Cystatin C inhibits amyloid-beta deposition in Alzheimer's disease mouse models.
    Mi W; Pawlik M; Sastre M; Jung SS; Radvinsky DS; Klein AM; Sommer J; Schmidt SD; Nixon RA; Mathews PM; Levy E
    Nat Genet; 2007 Dec; 39(12):1440-2. PubMed ID: 18026100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystatin C modulates cerebral beta-amyloidosis.
    Kaeser SA; Herzig MC; Coomaraswamy J; Kilger E; Selenica ML; Winkler DT; Staufenbiel M; Levy E; Grubb A; Jucker M
    Nat Genet; 2007 Dec; 39(12):1437-9. PubMed ID: 18026102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotype and plasma concentration of cystatin C in patients with late-onset Alzheimer disease.
    Chuo LJ; Sheu WH; Pai MC; Kuo YM
    Dement Geriatr Cogn Disord; 2007; 23(4):251-7. PubMed ID: 17310123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A dual Golgi- and mitochondria-localised Ala25Ser precursor cystatin C: an additional tool for characterising intracellular mis-localisation leading to increased AMD susceptibility.
    Ratnayaka A; Paraoan L; Spiller DG; Hiscott P; Nelson G; White MR; Grierson I
    Exp Eye Res; 2007 Jun; 84(6):1135-9. PubMed ID: 16635487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The relationship of cystatin C and cardiovascular diseases].
    Chen ZK; Ge CJ; Hu SJ
    Sheng Li Ke Xue Jin Zhan; 2003 Jul; 34(3):269-71. PubMed ID: 14628480
    [No Abstract]   [Full Text] [Related]  

  • 7. Rat cystatin C: inhibitor of granulocyte phagocytic functions.
    Leung-Tack J; Tavéra C; Er-Raki A; Gensac MC; Collé A
    Biol Chem Hoppe Seyler; 1990 May; 371 Suppl():255-8. PubMed ID: 2169253
    [No Abstract]   [Full Text] [Related]  

  • 8. Cystatins in non-small cell lung cancer: tissue levels, localization and relation to prognosis.
    Werle B; Schanzenbächer U; Lah TT; Ebert E; Jülke B; Ebert W; Fiehn W; Kayser K; Spiess E; Abrahamson M; Kos J
    Oncol Rep; 2006 Oct; 16(4):647-55. PubMed ID: 16969475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration of cystatin C in the cerebrospinal fluid of multiple sclerosis.
    Nakashima I; Fujinoki M; Fujihara K; Kawamura T; Nishimura T; Nakamura M; Itoyama Y
    Ann Neurol; 2007 Aug; 62(2):197-200; discussion 205. PubMed ID: 16958112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystatin C: research priorities targeted to clinical decision making.
    Shlipak MG
    Am J Kidney Dis; 2008 Mar; 51(3):358-61. PubMed ID: 18295049
    [No Abstract]   [Full Text] [Related]  

  • 11. Extracellular quality control in the epididymis.
    Cornwall GA; von Horsten HH; Swartz D; Johnson S; Chau K; Whelly S
    Asian J Androl; 2007 Jul; 9(4):500-7. PubMed ID: 17589787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystatin C binds serum amyloid A, downregulating its cytokine-generating properties.
    Bokarewa M; Abrahamson M; Levshin N; Egesten A; Grubb A; Dahlberg L; Tarkowski A
    J Rheumatol; 2007 Jun; 34(6):1293-301. PubMed ID: 17552057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cleavage of cystatin C is not associated with multiple sclerosis.
    Del Boccio P; Pieragostino D; Lugaresi A; Di Ioia M; Pavone B; Travaglini D; D'Aguanno S; Bernardini S; Sacchetta P; Federici G; Di Ilio C; Gambi D; Urbani A
    Ann Neurol; 2007 Aug; 62(2):201-4; discussion 205. PubMed ID: 17006926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse stefins A1 and A2 (Stfa1 and Stfa2) differentiate between papain-like endo- and exopeptidases.
    Mihelic M; Teuscher C; Turk V; Turk D
    FEBS Lett; 2006 Jul; 580(17):4195-9. PubMed ID: 16831429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystatin C in cerebrospinal fluid and multiple sclerosis.
    Hansson SF; Simonsen AH; Zetterberg H; Andersen O; Haghighi S; Fagerberg I; Andréasson U; Westman-Brinkmalm A; Wallin A; Rüetschi U; Blennow K
    Ann Neurol; 2007 Aug; 62(2):193-6; discussion 205. PubMed ID: 16900522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solubilized cystatin C amyloid is cytotoxic to cultured human cerebrovascular smooth muscle cells.
    Vilhjalmsson DT; Blöndal H; Thormodsson FR
    Exp Mol Pathol; 2007 Dec; 83(3):357-60. PubMed ID: 17963746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emerging role of cystatins in Alzheimer's disease.
    Zerovnik E
    Bioessays; 2009 Jun; 31(6):597-9. PubMed ID: 19382231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystatins from filarial parasites: evolution, adaptation and function in the host-parasite relationship.
    Gregory WF; Maizels RM
    Int J Biochem Cell Biol; 2008; 40(6-7):1389-98. PubMed ID: 18249028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystatin C reduces the in vitro formation of soluble Abeta1-42 oligomers and protofibrils.
    Selenica ML; Wang X; Ostergaard-Pedersen L; Westlind-Danielsson A; Grubb A
    Scand J Clin Lab Invest; 2007; 67(2):179-90. PubMed ID: 17365997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 3 cystatins; fetuins, kininogen and histidine-rich glycoprotein.
    Lee C; Bongcam-Rudloff E; Sollner C; Jahnen-Dechent W; Claesson-Welsh L
    Front Biosci (Landmark Ed); 2009 Jan; 14(8):2911-22. PubMed ID: 19273244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.